# STOCKHOLM 1.0
#=GF ID   ALKL1_2
#=GF AC   PF15129.10
#=GF DE   ALK and LTK ligand 1/2
#=GF PI   FAM150;
#=GF AU   Eberhardt R;0000-0001-6152-1369
#=GF AU   Coggill P;0000-0001-5731-1588
#=GF AU   Hetherington K;
#=GF SE   Jackhmmer:Q6UX46
#=GF GA   27.00 27.00;
#=GF TC   28.10 27.50;
#=GF NC   24.90 24.80;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 --cpu 4 -Z 75585367 HMM pfamseq
#=GF TP   Family
#=GF RN   [1]
#=GF RM   26630010
#=GF RT   Augmentor alpha and beta (FAM150) are ligands of the receptor
#=GF RT   tyrosine kinases ALK and LTK: Hierarchy and specificity of
#=GF RT   ligand-receptor interactions.
#=GF RA   Reshetnyak AV, Murray PB, Shi X, Mo ES, Mohanty J, Tome F, Bai
#=GF RA   H, Gunel M, Lax I, Schlessinger J;
#=GF RL   Proc Natl Acad Sci U S A. 2015;112:15862-15867.
#=GF RN   [2]
#=GF RM   26418745
#=GF RT   FAM150A and FAM150B are activating ligands for anaplastic
#=GF RT   lymphoma kinase.
#=GF RA   Guan J, Umapathy G, Yamazaki Y, Wolfstetter G, Mendoza P,
#=GF RA   Pfeifer K, Mohammed A, Hugosson F, Zhang H, Hsu AW, Halenbeck R,
#=GF RA   Hallberg B, Palmer RH;
#=GF RL   Elife. 2015;4:e09811.
#=GF RN   [3]
#=GF RM   34646012
#=GF RT   Structural basis of cytokine-mediated activation of ALK family
#=GF RT   receptors.
#=GF RA   De Munck S, Provost M, Kurikawa M, Omori I, Mukohyama J, Felix
#=GF RA   J, Bloch Y, Abdel-Wahab O, Bazan JF, Yoshimi A, Savvides SN;
#=GF RL   Nature. 2021;600:143-147.
#=GF RN   [4]
#=GF RM   34819673
#=GF RT   Mechanism for the activation of the anaplastic lymphoma kinase
#=GF RT   receptor.
#=GF RA   Reshetnyak AV, Rossi P, Myasnikov AG, Sowaileh M, Mohanty J,
#=GF RA   Nourse A, Miller DJ, Lax I, Schlessinger J, Kalodimos CG;
#=GF RL   Nature. 2021;600:153-157.
#=GF DR   INTERPRO; IPR029364;
#=GF DR   SO; 0100021; polypeptide_conserved_region;
#=GF CC   This entry includes ALK and LTK ligand 1 and 2 (ALKL1/2, also
#=GF CC   known as FAM150A and B, respectively) from vertebrates. ALKL1/2
#=GF CC   are activating ligands for the receptor anaplastic lymphoma
#=GF CC   kinase (ALK) and the receptor leukocyte tyrosine kinase (LTK)
#=GF CC   [1,2]. However, ALKL1 does not act as a potent physiological
#=GF CC   ligand for ALK, in contrast to ALKL2 [2,3]. Monomeric ALKAL1
#=GF CC   binds to LTK, leading to LTK homodimerisation and activation. It
#=GF CC   is not yet clear  if ALKL2 activates ALK as a homodimer or a
#=GF CC   monomer [3,4].
#=GF SQ   9
#=GS G1LSJ5_AILME/31-149      AC G1LSJ5.2
#=GS G1KE11_ANOCA/38-157      AC G1KE11.2
#=GS W5NL05_LEPOC/81-207      AC W5NL05.1
#=GS AKL2B_DANRE/76-195       AC E7FAP8.1
#=GS A0A669CK06_ORENI/41-163  AC A0A669CK06.1
#=GS W5MF77_LEPOC/33-156      AC W5MF77.1
#=GS M4AVG6_XIPMA/33-156      AC M4AVG6.1
#=GS ALKAL_TETNG/33-157       AC Q4RU86.1
#=GS H0WG53_OTOGA/33-154      AC H0WG53.1
G1LSJ5_AILME/31-149                 DRQTLLRLIVEILQELKKYHSGESKRLP...LSGQHDYTLGRREAS....DYPVYPEEQRV..EIVPRDLRMKDKFLKHLT.GPLYFSPKCSKHFHRLYHNTRDCTIPAYYKRCARLLTRLAVSPMCME.
G1KE11_ANOCA/38-157                 DRQNLLNLIMEILQELKRVRLEEDEENGVQYKH...DYLLGRRQLP....DYAADSEEQRV..EIVPRDLRMKDKFLNHLT.GHLYFGPKCTKHFHRLYHHTRDCTTPAYYKRCARLLTRLAVSPMCMEG
W5NL05_LEPOC/81-207                 NSQALLKLIMDTVKHLKKHHTEQN.ENIVQYISKHSDYSLDPKEQQHIDKSYHEDHHEDHI.VEIFPRDLRTKEKFLKHLT.GPLTVSPKCSKHFYRLYHNTRDCTIPAYYRRCARLLTRLAGSSRCMEG
AKL2B_DANRE/76-195                  DETSLLELLMDRVRQTQEHHSEGNTQHPPQII....EHSLETKDVN....KVTKSYQHERI.LEVFPRDLRQKDKFLKHLT.GPLYFSPKCSKLFYKLYNNTRDCTIPAYYKRCARLLTRLAGSQRCTEG
A0A669CK06_ORENI/41-163             DEQQDLRRMVEIVKQVEGSRGRHSAKTEAPAISRETSSPMEQKDFR....DLKAFRGNQAV..AIFPRDLRKKEKFIKYLT.GPLSFSPKCRKSVYKLYHHTRDCTIPAYFKRCARLLTRLAGSPQCTEG
W5MF77_LEPOC/33-156                 ERRTLLDLIMQVIGDNQG.DKSVSRRYTSGLYSVDQDYKFSSREKA....LFFPRLDNSRP.IEIVPRDVNLKDKFIKHFTAGPVKFSSECRTHFHRLYHNTRDCSTPAYYKRCARLLTRLAMSPLCTQS
M4AVG6_XIPMA/33-156                 ERRTLLDLILQVIKDSQQRDKPVSRRCGSGLHTSAQDFKSSSREKP....LYVPRLDNTRL.IDIVSRDADLKNKFIQHFG.GHVKFSSECKTHFHRLYYTTRDCSTPAYYKRCARLLTRLAMSPLCMQS
ALKAL_TETNG/33-157                  ERRTLLDLILQVIRDSQQREKNTSRRCIAGLLTSAQDMKLSSPEKP....FYIPRLDNSRL.IEIFPRDLNMKGKFIQHFTAGPVKFSSECRIQFHRLYHNTRDCSRPAYYKRCARLLTRLAMSPLCMQS
H0WG53_OTOGA/33-154                 DGQTLLRLLVEIVQELKKHQSGE...YARPQPHGGQDCAPAHSQVL....DFGPSQDEQRVETEIVPRDLRMKDKFLKHLT.GPLYFSPKCSKHFHRLYHNTRDCTIPAYYKRCARLLTRLAVSPACVEG
#=GC seq_cons                       -cpoLLcLIh-llp-hpppcpppspcpssthhottpDaphup+-hs....pahsph-ppRl.hEIhPRDLRhK-KFlKHLT.GPLhFSPKCpKHFHRLYHNTRDCThPAYYKRCARLLTRLAsSPhChEu
